Mark Cuban on Drugs, Investing, and Advice for Jeff Bezos

Mark Cuban on Drugs, Investing, and Advice for Jeff Bezos

The big three healthcare companies aren’t paying much attention to Mark Cuban’s new health care venture, Cost Plus Drugs. But their margins could mean a huge opportunity for the new start-up. Chris Hill caught up with Cuban to discuss: - Why he’s able to sell a leukemia drug for thousands of dollars less than competitors - Stocks he bought during the pandemic - Advice for potential NFL owner Jeff Bezos To check out Mark's new business go to www.CostPlusDrugs.com Companies mentioned: WBA, CVS, NFLX, LYV, LVS, AMZN Host: Chris Hill Guest: Mark Cuban Producer: Ricky Mulvey Engineers: Dan Boyd, Austin Morgan, Tim Sparks Learn more about your ad choices. Visit megaphone.fm/adchoices

Avsnitt(2130)

Three Stocks for a Tougher Economy

Three Stocks for a Tougher Economy

In today’s episode of Motley Fool Money, host Emily Flippen is joined by analysts Sanmeet Deo and Dan Caplinger as each gives a stock pick they think can outperform in a “worst case” economic environm...

17 Feb 19min

Are Unity and Zillow Resilient Brands?

Are Unity and Zillow Resilient Brands?

Why do companies with strong consumer appeal tend to outperform? The team breaks down the elements of a resilient brand and then uses that lends to discuss recent financial results from Unity Software...

16 Feb 22min

Thriving with Anxiety

Thriving with Anxiety

How can we harness our anxiety in everything from parenting to investing? Motley Fool analyst Jason Moser talks with psychologist Dr. David Rosmarin, author of Thriving with Anxiety: Nine Tools To Mak...

15 Feb 24min

A Couple’s Financial Manifesto, Revisited

A Couple’s Financial Manifesto, Revisited

It’s Valentine’s Day, and there’s nothing more romantic than talking about money with your partner. Well, maybe not. But it is important because studies show that financial acrimony can lead to marita...

14 Feb 21min

The Week's Growth Wasn’t Enough For Wall Street

The Week's Growth Wasn’t Enough For Wall Street

We saw a rush of earnings reports this week and while results looked solid, stocks often cratered on fear of AI and disruption. We discuss our takeaways and where there may be value for investors. The...

13 Feb 42min

Shopify’s Whiplash Day

Shopify’s Whiplash Day

It looked like Shopify’s stock was headed for a great day when it reported earnings, only for the stock to give up all its gains and then some when management started talking on the conference call. T...

12 Feb 24min

Subscription Prices Are Going Up Again

Subscription Prices Are Going Up Again

Subscription prices are going up across the board and that may be the norm for the foreseeable future. Then we discuss the state of retail spending and why Unity’s stock dropped 30% on fear AI will di...

11 Feb 16min

Rule Breaker Earnings Roundup

Rule Breaker Earnings Roundup

In today’s episode of Motley Fool Money, host Emily Flippen is joined by analysts Jason Hall and Toby Bordelon to break down earnings from three of the most volatile Rule-Breaking stocks out there. Th...

10 Feb 23min

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-jossan-nina
rss-borsens-finest
svd-tech-brief
uppgang-och-fall
rss-svart-marknad
avanzapodden
dynastin
borsmorgon
rss-dagen-med-di
rss-kort-lang-analyspodden-fran-di
24fragor
fill-or-kill
ekonomiekot-extra
lastbilspodden
rss-den-nya-ekonomin
tabberaset
rss-veckans-trade